SCHEMBL6849286

SCHEMBL6849286

O=C(NC1CC2CCN1C2)c1cc2sc(C(=O)C(F)(F)F)cc2cn1

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 17/20 0.46
HTR3A P46098 5/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6849181 0.87 CHRNA7 (0.48) CHRNA7HTR3A
SCHEMBL6850983 0.86 CHRNA7 (0.47) CHRNA7HTR3A
SCHEMBL844106 0.86 CHRNA7 (0.64) CHRNA7HTR3A
SCHEMBL844105 0.86 CHRNA7 (0.64) CHRNA7HTR3A
SCHEMBL6849602 0.85 CHRNA7 (0.46) CHRNA7HTR3A
SCHEMBL6848418 0.85 CHRNA7 (0.49) CHRNA7HTR3A
SCHEMBL6848523 0.85 CHRNA7 (0.44) CHRNA7HTR3A
SCHEMBL6849574 0.84 CHRNA7 (0.50) CHRNA7HTR3A
SCHEMBL6849360 0.83 CHRNA7 (0.49) CHRNA7HTR3A
SCHEMBL6849135 0.82 CHRNA7 (0.48) CHRNA7HTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432707-A1 AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2004-06-30 EP claimed
WO-2003029252-A1 AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2003-04-10 WO claimed
EP-1432707-A1 AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2004-06-30 EP disclosed
WO-2003029252-A1 AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2003-04-10 WO disclosed